| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-07-16 | Taub Rebecca | Director | Sale+OE | 15,718 | $353.11 | $5,550,191.92 | -0.8% | → |
| 2025-07-16 | FRIEDMAN PAUL A | Director | Sale+OE | 26,176 | $353.47 | $9,252,543.02 | -1.9% | → |
| 2025-03-13 | CRAVES FRED B | Director | Sale+OE | 15,470 | $328.54 | $5,082,479.62 | -0.3% | → |
| 2025-03-10 | Dier Mardi | SVP and CFO | Sell | 258 | $323.04 | $83,344.32 | -2.4% | → |
| 2025-03-05 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Sale+OE | 14,113 | $341.32 | $4,817,103.60 | -12.2% | → |
| 2025-03-03 | Dier Mardi | SVP and CFO | Sell | 1,961 | $324.96 | $637,248.06 | -11.8% | → |
| 2025-03-03 | Huntsman Carole | Chief Commercial Officer | Sell | 1,834 | $325.98 | $597,839.68 | -2.1% | → |
| 2025-03-03 | Kelley Shannon T | General Counsel | Sell | 415 | $335.00 | $139,025.00 | -5.4% | → |
| 2025-02-28 | Waltermire Robert E. | Senior VP, Chief Pharma Dev. | Sell | 1,227 | $341.07 | $418,488.05 | -13.9% | → |
| 2025-02-27 | BATE KENNETH | Director | Sale+OE | 600 | $351.83 | $211,095.73 | -1.4% | → |